S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Michael J. Fox and Harrison Ford Team Up to Demystify Parkinson’s

When a friend receives a Parkinson’s diagnosis, knowing how to respond can feel daunting. Michael J. Fox and Harrison Ford are tackling that awkwardness head-on in a new awareness campaign, using their real-life rapport to demonstrate that the most important step is simply showing up for those you love.

Michael J. Fox and Harrison Ford Team Up to Demystify Parkinson’s
Photo: Bio & News

The campaign, titled "So…Your Friend Has Parkinson's," was developed by Ryan Reynolds’ production company, Maximum Effort. The project features the two actors in a candid, humorous exchange about the practical realities of the condition—ranging from handwriting struggles to the risk of social isolation. By leveraging the chemistry they built while filming the series Shrinking, the pair aims to strip away the discomfort often surrounding neurodegenerative diagnoses.

This initiative arrives as Parkinson’s remains the fastest-growing neurodegenerative disease globally, with cases projected to double by 2040. Beyond the video’s message of support, the campaign serves as a precursor to the Foundation’s upcoming $2.5-billion fundraising drive, "All Grit. No Quit." Since its inception in 2000, The Michael J. Fox Foundation has funneled over $3 billion into research, pushing the medical community toward what many experts describe as a critical inflection point in drug development and potential breakthroughs.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!